Jan‐Hinrich Guse

Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis

Andrea Mencarelli, Eleonora Distrutti, Barbara Renga et al. · European Journal of Pharmacology · 2011 · 59 citations

Inflammation, Rheumatology, Chronic Inflammatory Diseases +12

Vanillic Acid 4-<i>O</i>-β-D-(6′-<i>O</i>-Galloyl) Glucopyranoside and Other Constituents from the Bark of<i>Terminalia macroptera</i>Guill. Et Perr

Jürgen Conrad, Bernhard Vogler, Iris Klaiber et al. · Natural product letters · 2001 · 23 citations

AWD-12-281 (inhaled) (elbion/GlaxoSmithKline).

Hans-Jürgen Gutke, Jan‐Hinrich Guse, Moussa Khobzaoui et al. · PubMed · 2005 · 23 citations

Translational Medicine, 5-Hydroxyindole Pde4 Inhibitor, Advanced Lung Disease +14

Imidazoquinolines with improved pharmacokinetic properties induce a high IFNα to TNFα ratio in vitro and in vivo

Manuel Keppler, Simon Straß, Sophia Geiger et al. · Frontiers in Immunology · 2023 · 11 citations · Full text